Why This Matters

If you’re stocking kratom, kava, or considering either category, you’re navigating two completely different regulatory landscapes. Kratom faces active enforcement pressure, state-by-state bans, and a shifting federal posture on concentrated alkaloid products. Kava is federally legal, unscheduled, and growing as a retail category with minimal regulatory friction.

Both products drive margin and bring customers through your door, but the compliance risk, inventory strategy, and customer base are night and day. Here’s what you need to know to stock smart, stay compliant, and capture the opportunity without the headache.

Kratom vs Kava: The Basics

What They Are

Kratom is the leaf of Mitragyna speciosa, a tree native to Southeast Asia. The primary alkaloids—mitragynine and 7-hydroxymitragynine (7-OH)—interact with opioid receptors, though kratom is not an opioid. It’s sold as powder, capsules, extracts, shots, and increasingly as concentrated 7-OH products.

Kava is the root of Piper methysticum, a plant from the South Pacific. Its active compounds—kavalactones—produce relaxation and mild euphoria without the opioid-receptor interaction. It’s sold as powder, capsules, gummies, shots, teas, and extracts. Kava bars (similar to juice bars or coffee shops) are a growing retail format in urban markets.

They are not interchangeable. They are not in the same botanical family. They do not share a regulatory or compliance profile.

Kava is legal in all 50 states. It is not a controlled substance. There are no federal restrictions, no DEA scheduling discussions, and no state bans. The FDA does not regulate kava as a drug. You can stock it, sell it, and market it without the compliance landmines you face with kratom.

Kratom is legal federally but banned or restricted in a growing list of states. As of mid-2026, full state bans are in effect in Alabama, Arkansas, Connecticut, Indiana, Kansas (effective July 2026), Louisiana, Michigan, Vermont, and Wisconsin. Tennessee has a ban pending the governor’s signature. California enacted a de facto commercial ban via administrative action by the California Department of Public Health in October 2025—not a legislative ban, but it effectively prohibits the sale of kratom and 7-OH products statewide.

Rhode Island reversed its kratom ban effective April 1, 2026, under the Kratom Consumer Protection Act (KCPA).

More than 18 states have passed KCPA legislation, which regulates kratom through age verification, labeling requirements, third-party lab testing, and bans on adulterated or synthetic kratom products. Several KCPA states—Arizona, Oklahoma, Colorado, Texas, and Utah—cap 7-hydroxymitragynine at 2% of total alkaloid content, effectively banning high-concentration 7-OH extracts while keeping natural kratom products legal.

Federal Pressure on 7-OH

In July 2025, the FDA recommended that the DEA place concentrated 7-hydroxymitragynine on Schedule I. The DEA has not acted as of this writing. Florida banned 7-OH via emergency rule in August 2025.

If you carry concentrated 7-OH shots or extracts, you are sitting on inventory that could become federally illegal with minimal notice. The compliance clock is ticking.

Why Shop Owners Stock Them

Kratom: High Margin, High Risk

Kratom is a proven traffic driver. Customers buy frequently—often weekly or more—and many are brand-loyal. Margins on powder and capsules typically run 40-60%, and higher on extracts and shots.

But the regulatory risk is real. State laws are changing fast. If your state enacts a ban or a strict KCPA with testing and labeling mandates, you could be sitting on dead inventory or facing compliance costs that eat your margin.

Kava: Growth Category, New Customer Base

Kava brings in a different customer than your core smoke shop traffic. It appeals to wellness-oriented buyers, people looking for alcohol alternatives, and customers who might never buy kratom or nicotine products.

Margins are solid—comparable to kratom—but without the compliance overhead. Kava shots, gummies, and instant powder mixes are easy to stock, shelf-stable, and straightforward to explain to staff.

Kava bars are also emerging as standalone retail concepts, similar to the kratom bar trend. If you have the space and foot traffic, a kava bar setup (small drink station with kava shots or brewed kava) can drive impulse sales and dwell time.

Stocking Strategies

Kratom: Know Your State, Know Your Vendor

If you’re in a KCPA state, confirm your vendor can provide:

  • Third-party lab reports (alkaloid content, heavy metals, microbial contamination)
  • Compliant labeling (age warning, alkaloid content, batch number, expiration date)
  • Documentation that products are not adulterated or fortified with synthetic alkaloids

If your state caps 7-OH at 2%, verify that extracts and shots fall within the limit. Many legacy 7-OH products do not.

If you’re in a state without a ban or KCPA, you still have exposure. California’s administrative ban caught many shops off guard. Track your state’s legislative calendar and be ready to pull inventory if a ban advances.

Kava: Stock for Trial and Repeat

Kava customers often start with a shot or a single-serving product. Stock a range of formats:

  • Shots: High margin, impulse-friendly, easy to explain.
  • Instant powder or capsules: For repeat buyers who want better per-dose economics.
  • Gummies or chews: Appeals to customers who don’t like the taste of kava (which is notoriously earthy and bitter).

Taste is a barrier. Kava has a distinct, peppery, slightly numbing flavor. Shots and flavored gummies solve this. If you’re doing in-store sampling, kava shots are easier than kratom (no opioid-receptor concerns, fewer compliance worries).

Inventory Velocity and Shelf Life

Both kratom and kava are shelf-stable, but kratom powder oxidizes over time. If you’re not turning inventory every 60-90 days, you risk product degradation and customer complaints.

Kava is more forgiving. Properly stored kava powder or capsules can last 12-24 months. Shots and gummies have similar or longer shelf lives.

Margin and Pricing

Kratom

  • Powder (bulk bags, 100-250g): $15-40 retail, $6-16 wholesale. Margin: 50-60%.
  • Capsules (30-60 count): $10-25 retail, $4-10 wholesale. Margin: 50-60%.
  • Extracts and shots: $10-30 retail, $3-10 wholesale. Margin: 60-70%.

High-concentration 7-OH products command premium pricing, but they are also the highest-risk category from a regulatory standpoint.

Kava

  • Shots (1.5-2 oz): $8-15 retail, $3-6 wholesale. Margin: 50-60%.
  • Powder (4-8 oz instant or traditional): $15-35 retail, $6-14 wholesale. Margin: 50-60%.
  • Capsules (30-60 count): $15-30 retail, $6-12 wholesale. Margin: 50-60%.
  • Gummies (10-20 count): $12-25 retail, $5-10 wholesale. Margin: 50-60%.

Kava pricing is comparable to kratom, and customers often perceive kava as a premium wellness product, which can support higher price points.

Compliance and Risk Management

Kratom

High compliance risk. Track your state’s legal status monthly. Subscribe to industry newsletters (American Kratom Association, state retail associations) and monitor your state legislature.

If your state passes a KCPA, you will need to:

  • Verify all products meet labeling and testing requirements.
  • Ensure vendors provide lab reports and compliance documentation.
  • Remove any products that exceed 7-OH caps or contain synthetic alkaloids.

If your state enacts a ban, you may have a grace period to sell through inventory, or you may need to pull products immediately. Plan for this. Do not overstock in states where a ban is under consideration.

Federal exposure: The FDA’s recommendation to schedule concentrated 7-OH is still pending DEA action. If the DEA schedules 7-OH, you will need to remove all 7-OH extracts and high-concentration shots from your shelves. Monitor federal updates and be ready to act.

Kava

Low compliance risk. Kava is not scheduled, not banned, and not under active federal or state enforcement pressure. You do not need to track changing laws state by state.

The FDA has issued warnings in the past about kava and liver toxicity, but these warnings were based on European cases involving non-traditional kava preparations (aerial parts of the plant, alcohol extracts). Traditional kava root products have a long history of safe use in the South Pacific.

You should still ensure your vendor sources from reputable suppliers and provides documentation of origin and purity, but the compliance burden is minimal compared to kratom.

What to Watch

Kratom

  • State legislative sessions: Several states are considering kratom bans or KCPA bills. Track your state’s legislative calendar.
  • DEA action on 7-OH: The FDA’s recommendation is still pending. A federal ban on concentrated 7-OH could happen with little notice.
  • California enforcement: California’s administrative ban is new. Watch for enforcement actions and clarifications on what products are covered.
  • KCPA adoption: More states are passing KCPA laws. If your state adopts a KCPA, you will need to verify vendor compliance and update inventory.

Kava

  • Category growth: Kava bars and kava-focused retail concepts are expanding. If you have the foot traffic and space, a small kava drink station could drive incremental sales.
  • Format innovation: Watch for new delivery formats—seltzers, ready-to-drink beverages, fast-acting gummies. These appeal to wellness and alcohol-alternative customers.
  • Vendor consolidation: As kava grows, larger CPG brands are entering the space. This could bring better margins, more marketing support, and higher-quality products.

Actionable Takeaways

  1. Do not treat kratom and kava as interchangeable. They are different plants, different legal statuses, different compliance risks.
  2. If you stock kratom, track your state’s legal status every month. Laws are changing fast.
  3. If you’re in a KCPA state, verify your kratom vendor provides lab reports and compliant labeling. You are responsible for what’s on your shelves.
  4. If you carry concentrated 7-OH products, understand the federal and state risk. The FDA has recommended Schedule I placement, and several states have already banned 7-OH.
  5. Stock kava to diversify your customer base. It brings in wellness-oriented buyers who might not be traditional smoke shop customers.
  6. Start kava customers with shots or gummies. Taste is a barrier; these formats solve it.
  7. Monitor inventory velocity. Both categories are shelf-stable, but kratom degrades over time. Don’t overstock in states with pending bans.

FAQ

Are kratom and kava the same thing?

No. Kratom is the leaf of Mitragyna speciosa, a tree from Southeast Asia. Kava is the root of Piper methysticum, a plant from the South Pacific. They have different active compounds, different effects, and completely different legal statuses.

Is kava legal in all 50 states?

Yes. Kava is not a controlled substance and is legal to sell in all 50 states. There are no federal or state bans on kava.

Is kratom legal in my state?

It depends. As of mid-2026, kratom is banned in Alabama, Arkansas, Connecticut, Indiana, Kansas (effective July 2026), Louisiana, Michigan, Vermont, Wisconsin, and California (via administrative action). Tennessee has a pending ban. Rhode Island reversed its ban in April 2026. More than 18 states have passed the Kratom Consumer Protection Act, which regulates but does not ban kratom. Check your state’s current status and consult your state regulator or industry association.

What is 7-hydroxymitragynine (7-OH)?

7-OH is one of the alkaloids in kratom, present in small amounts in the natural plant. Concentrated 7-OH products—extracts and shots with high levels of isolated 7-OH—are the focus of federal and state regulatory action. The FDA recommended Schedule I placement in July 2025, and several states have capped or banned 7-OH products.

Should I stock both kratom and kava?

If you’re in a state where kratom is legal and you can manage the compliance risk, both categories can drive margin and foot traffic. They appeal to different customer bases. Kava is lower-risk and brings in wellness-oriented buyers. Kratom drives repeat purchases but requires active compliance monitoring. Stock based on your state’s legal landscape, your risk tolerance, and your customer base.